Trial Profile
Phase II trial of secretin in patients with schizophrenia.
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 16 Apr 2012
Price :
$35
*
At a glance
- Drugs Secretin (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 21 Oct 2005 New trial record.